Commentary
Adrenal myelolipomas are nonfunctioning benign tumors composed of adipose tissue and hemopoietic elements resembling bone marrow. [1] The lesion was first described by Glerke in 1905 and coined as "myelolipoma" by Oberling in 1929. [2] Initially, myelolipomas were detected incidentally during autopsy with a detection rate of 0.08%-0.2%. However, with the advent of computed tomography (CT) scan and magnetic resonance imaging, more adrenal myelolipomas are being reported, with <300 cases being detected by the year 2000. [3] Adrenal myelolipomas are rare, benign, nonfunctioning tumors composed of mature adipose tissue and hemopoietic elements. They comprise 5.8% of adrenal tumors, with a male-to-female ratio of 1.3:1. They are usually unilateral with right-sided predominance but may be occasionally bilateral with extra-adrenal involvement such as retroperitoneum, thorax, and pelvis. [4] Adrenal myelolipomas are associated with four distinct clinicopathological syndromes which include (a) isolated adrenal myelolipoma, (b) adrenal myelolipoma associated with acute hemorrhage, (c) extra-adrenal myelolipoma, and (d) adrenal myelolipoma associated with other adrenal disorder.
Usually, adrenal myelolipomas are <4 cm in size, but, occasionally, giant myelolipomas have been reported. The largest myelolipoma was reported first by Pagana TJ et al. which measured 31 cm × 24.5 cm × 11.5 cm and weighed 6 kg. [5] The first excision of a myelolipoma was carried out in 1922. Since then, >100 cases of surgically resected adrenal myelolipomas have been documented. They affect patients in their fourth to sixth decades, may be clinically asymptomatic, or may present with dull-aching, abdominal pain which can be misinterpreted as retroperitoneal liposarcomas on radiological examination. [6] The exact pathogenesis of adrenal myelolipomas remains unclear. Various theories have been suggested regarding their pathogenesis; however, the most favored theory is metaplasia of reticuloendothelial cells of blood vessels in response to external stimuli. [7] Initially, patients with myelolipoma underwent surgical recession. Nowadays treatment is decided by the size of the tumor. When the tumor size is 4 cms or less and are asymptomatic, serial followup is recommended.
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